Abstract
Purpose Nutritional status changes in breast cancer patients during treatment are prevalent. However, the metabolic implications of those alterations are poorly understood. We aimed to characterize body composition, lipids, glucose levels, and indices that express cardiovascular risk in breast cancer patients after completion of chemotherapy and then to compare those results with a matched control group.
Methods A cross-sectional study was performed. Women who completed their chemotherapy were recruited (BC group) and compared with a group of non-malignant age- and body mass index-matched (MC group), as well as a group of healthy, non-malignant women (HC group). Body composition by bioelectrical impedance analysis, handgrip strength, and blood sample were collected. Visceral adiposity, triglyceride glucose and lipid accumulation product indices were calculated. Food consumption was assessed.
Results 88 women were included (BC=36, MC=36, HC=16). BC patients demonstrated worse values of phase angle, nutritional risk index, extracellular body water to total body water ratio and lower handgrip strength. Additionally, those women had impairments in lipids, worst glucose levels, visceral fat dysfunction and consequently higher cardiovascular risk, presenting important unhealthy dietary patterns with higher carbohydrate and caloric intake and insufficient protein and fiber ingestion. No differences were observed between MC and HC.
Conclusion Breast cancer patients present unhealthy metabolic, nutritional, and dietetic features when compared to a group of age- and BMI-matched non-malignant females. Also, breast cancer patients had higher levels of cardiovascular risk. Further investigations are required to examine the underlying mechanisms and the potential longitudinal changes during surveillance time.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
BRS was founded by São Paulo Research Foundation (FAPESP). Grant number: 2017/07963-0 and FAPESP scholarship number: 2019/09877-9. LAPC was founded by CoordenaÃ𝕊ão de AperfeiÃ𝕊oamento de Pessoal de NÃ-vel Superior ? CAPES Brasil (Coordination for the Improvement of Higher Education Personnel, in free translation) ? Financing Code 001 Doctoral scholarship granted.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institutional Review Board at the University of São Paulo, General Hospital, approved the current study, protocol number: HCRP 14608/2017.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Not Applicable
Data Availability
All relevant data are within the manuscript.